Youngevity's Delisting Status
Youngevity is in severe trouble, and notwithstanding the pump and dump of the past few days which will surely attract SEC attention, Youngevity is not going to make it to the end of the year without inflicting even greater losses on investors. Nasdaq has already delisted Youngevity. SEC filing in October state that a 15 day stay of the delisting is in effect until a hearing on November 5th. A stay doesn't change Nasdaq's decision to delist Youngevity. Youngevity needs to win the hearing in order to change their delisting status. After failing to file its 2019 10k, first quarter 2020 Q, second quarter 2020 Q, having their accountant resign, acknowledging the need to restate its 1Q, 2Q, and 3Q 2019 filings, and failing the $1 minimum share price requirement, Youngevity has ZERO hope of avoiding being thrown off the Nasdaq. When it does, the price is going to fall to 25 cents on November 6th and it's going to hurt investors badly. Failure to understand the severity of YGYI's situation and comments defending the company is going to cause people to lose even more of their investment. These comments are intended to warn people to abandon this sinking ship as I've done since the price of YGYI was $3. Youngevity is not coming back. Investors should sell now ahead of the November 5th hearing to preserve what little of their capital remains.
